Gordon Moody
Seminars
Friday 26th September 2025
Strategies to Overcome Challenges with Development of Cell Therapy for Solid Tumors
10:00 am
- Advancing innovative strategies to ‘armor’ cell therapies with the goal of enabling them to resist the immuno-suppressive TME
- We are advancing a portfolio of CAR-Ts and TCR-Ts that aim to unlock a range of important targets in cancer. Preclinical and early clinical data are showing the potential of our approach across hard-to-treat solid cancers
- Beyond our work in solid tumors, we are advancing a novel dual-targeting CAR-T that has potential in hematology and immunology, and which uses a rapid manufacturing process to overcome current challenges in the production of cell therapies
